医学
2型糖尿病
肾脏疾病
电子病历
儿科
糖尿病
肾功能
病历
疾病
梅德林
家庭医学
初级保健
临床实习
小儿内分泌
2型糖尿病
重症监护医学
1型糖尿病
电子健康档案
内科学
医疗之家
以患者为中心的结果
青少年医学
作者
Paul MacDaragh Ryan,Jill Hamilton,Elizabeth A. C. Sellers,EDGAR DELBERT,MELISSA DEL VECCHIO,Carrie Costello,Kalie L. Tommerdahl,Petter Bjornstad,Allison B. Dart,Brandy Alexandra Wicklow
摘要
INTRODUCTION: Assess current diabetic kidney disease (DKD) screening practices in adolescents with type 2 diabetes (T2D), identify the comfort level of pediatric endocrinologists in interpreting and treating kidney dysfunction, and investigate barriers and facilitators to implementation of estimated glomerular filtration rate (eGFR) as an adjunctive surveillance metric. METHODS: An anonymous survey was distributed via email to North American pediatric endocrinologists. RESULTS: A total of 115 pediatric endocrinologists (Canada, n = 40, USA, n = 75) with mean 12.4 (SD 10.3) years in practice, largely from tertiary care centers, completed the survey. Most respondents screen for DKD at T2D diagnosis and annually thereafter. Exposure to an electronic medical record screening prompt was associated with complete adherence. Random urine albumin-to-creatinine ratio was the most common test, while most respondents never ordered an eGFR for DKD surveillance. Discomfort with eGFR interpretation was common, with only one-quarter recognizing hyperfiltration as a clinical concern. Respondents would be more likely to use eGFR if it was externally validated, endorsed by a major society, or incorporated into clinical practice guidelines, with automated electronic medical record reporting as the preferred implementation method. CONCLUSION: Pediatric endocrinologists demonstrate fidelity to pediatric T2D DKD screening clinical practice guidelines; however, comfort with eGFR interpretation in this setting remains limited.
科研通智能强力驱动
Strongly Powered by AbleSci AI